Cytek Biosciences Inc (CTKB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 90,853 | 93,281 | 75,470 | 95,299 | 98,745 |
| Marketable Securities | 170,676 | 168,453 | 186,552 | 170,314 | 179,145 |
| Receivables | 62,509 | 56,632 | 56,232 | 55,029 | 60,588 |
| Inventories | 48,428 | 51,649 | 49,487 | 45,347 | 43,893 |
| TOTAL | $391,996 | $388,489 | $382,825 | $380,501 | $396,446 |
| Non-Current Assets | |||||
| PPE Net | 18,009 | 18,046 | 18,352 | 17,834 | 17,962 |
| Intangibles | 33,518 | 34,374 | 35,308 | 36,109 | 36,791 |
| Other Non-Current Assets | 18,019 | 54,010 | 56,835 | 48,152 | 48,301 |
| TOTAL | $69,546 | $106,430 | $110,495 | $102,095 | $103,054 |
| Total Assets | $461,542 | $494,919 | $493,320 | $482,596 | $499,500 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,410 | 7,632 | 6,853 | 6,247 | 5,529 |
| Accrued Expenses | 23,417 | 20,233 | 21,604 | 19,197 | 21,443 |
| Other current liabilities | 19,473 | 18,603 | 16,685 | 14,541 | 15,199 |
| TOTAL | $77,804 | $75,207 | $73,270 | $67,691 | $67,663 |
| Non-Current Liabilities | |||||
| Long Term Debt | 525 | 655 | 791 | 918 | 1,050 |
| Deferred Revenues | 28,504 | 28,739 | 28,128 | 27,706 | 25,492 |
| Other Non-Current Liabilities | 23,135 | 24,171 | 25,077 | 18,647 | 18,952 |
| TOTAL | $41,999 | $41,141 | $42,493 | $35,282 | $36,100 |
| Total Liabilities | $119,803 | $116,348 | $115,763 | $102,973 | $103,763 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 128,550 | 127,865 | 127,224 | 126,659 | 128,097 |
| Common Shares | 129 | 128 | 127 | 128 | 129 |
| Retained earnings | -101,738 | -57,662 | -52,184 | -46,601 | -35,199 |
| Other shareholders' equity | 2,241 | 821 | -38 | -609 | 16 |
| TOTAL | $341,739 | $378,571 | $377,557 | $379,623 | $395,737 |
| Total Liabilities And Equity | $461,542 | $494,919 | $493,320 | $482,596 | $499,500 |